Vaginal misoprostol for pre-abortion cervical priming: Is there an optimal evacuation time interval?

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 106, Issue 3, 1999, Pages 266-269

  Singh, Kuldip ^a   Fong, Y F ^a   Prasad, R N V ^a   Dong, F ^b  

^a NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

MISOPROSTOL;

ABDOMINAL PAIN; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FEVER; FIRST TRIMESTER PREGNANCY; HUMAN; INTRAVAGINAL DRUG ADMINISTRATION; NORMAL HUMAN; PREGNANCY TERMINATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; UTERINE CERVIX DILATATION; VACUUM ASPIRATION; VAGINA BLEEDING;

ABORTION, DRUG INDUCED; ABORTION, INDUCED; ASIA; BIOLOGY; CERVICAL DILATATION; COMPARATIVE STUDIES; DEMOGRAPHIC FACTORS; DEVELOPING COUNTRIES; ENDOCRINE SYSTEM; FAMILY PLANNING; FERTILITY CONTROL, POSTCONCEPTION; MISOPROSTOL--ADMINISTRACTION AND DOSAGE; PHYSIOLOGY; POPULATION; POPULATION DYNAMICS; PROSTAGLANDINS; PROSTAGLANDINS, SYNTHETIC; RESEARCH METHODOLOGY; RESEARCH REPORT; SINGAPORE; SOUTHEASTERN ASIA; STUDIES; TIME FACTORS; TREATMENT;

ABORTIFACIENT AGENTS, NONSTEROIDAL; ABORTION, INDUCED; ADULT; CERVICAL RIPENING; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MISOPROSTOL; PREGNANCY; PROSPECTIVE STUDIES; TIME FACTORS;

EID: 0032984320     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.1999.tb08241.x     Document Type: Article

References (11)

1. Grimes DA, Schulz KF, Cates WJ. Prevention of uterine perforation during curettage abortion. JAMA 1984; 251: 2108–2111.
2. Schulz KF, Grimes DA, Cates WJ. Measures to prevent cervical injury during suction curettage abortion. Lancet 1983; i: 1182–1184.
3. 1 analogues, misoprostol and gemeprost. Lancet 1994; 343: 1207–1209.
4. Misoprostol and legal medical abortion [editorial]. Lancet 1991; 38: 1241–1242.
5. Lawrie A, Penney G, Templeton A. A randomized comparison of oral and vaginal misoprostol for cervical priming before suction termination of pregnancy. Br J Obstet Gynaecol 1996; 103: 1117–1119.
6. Singh K, Fong YF, Prasad RNV, Dong F. A randomised trial to deter- mine the optimal dose of vaginal misoprostol for pre-abortion cervical priming. Obstet Gynecol 1998; 92: 795–798.
7. Meinert CL. Clinical Trials: Design, Conduct and Analysis. Oxford : Oxford University Press, 1986.
8. Fisher LV, Van Belle G. Biosturistics; A Methodology for Health Services. Chichester : John Wiley Interscience Publications, 1993.
9. Fong YF, Singh K, Prasad RNV. A comparative study using two dose regimens (200 pg or 400 pg) of vaginal misoprostol for pre-operative cervical dilatation in first trimester nulliparae. Br J Obstet Gynaecol 1998; 105: 413–417.
10. Ficicioglu C, Tasdemir M, Tasdemir S. Effect of vaginal misoprosto1 application for cervical softening in pregnancy interruption before ten weeks of gestation. Acta Obstet Gynecol Scand 1996; 75: 54–56.
11. Bugalho A. Bique C, Almeida L, Bergstrom S. Application of vaginal misoprostol before cervical dilatation to facilitate first trimester pregnancy interruption. Obstet Gynecol 1994; 83: 729–731.